LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

<
<<
Previous
Page 1 of 497
Next
>>
>
1 to 25 of 12420 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Relative Growth Rate After Treatment
MCF 10A	AZD 5438	0.04	uM	LJP6	3	J06	72	hr	962	9569	10605	0.9023	0.8926
MCF 10A	AZD8055	0.04	uM	LJP6	2	A12	72	hr	962	3369	10605	0.3177	0.2496
MCF 10A	Alvocidib	0.04	uM	LJP6	1	A18	72	hr	962	614	10605	0.0579	-0.0361
MCF 10A	AZD 5438	0.04	uM	LJP6	2	J06	72	hr	962	9634	10605	0.9084	0.8993
MCF 10A	AZD7762	0.04	uM	LJP6	1	L06	72	hr	962	10327	10605	0.9738	0.9712
MCF 10A	AZD8055	0.04	uM	LJP6	1	A12	72	hr	962	2946	10605	0.2778	0.2057
MCF 10A	Afatinib	0.04	uM	LJP6	3	G24	72	hr	962	1751	10605	0.1651	0.0818
MCF 10A	Sigma A6730	0.04	uM	LJP5	3	B24	72	hr	962	10563	10605	0.9960	0.9956
MCF 10A	AT-7519	0.04	uM	LJP6	1	K06	72	hr	962	9345	10605	0.8812	0.8693
MCF 10A	AZD 5438	0.04	uM	LJP6	1	J06	72	hr	962	9656	10605	0.9105	0.9016
MCF 10A	AZD-6482	0.04	uM	LJP5	2	I06	72	hr	962	10744	10605	1.0131	1.0144
MCF 10A	AZD-6482	0.04	uM	LJP5	3	I06	72	hr	962	10176	10605	0.9595	0.9555
MCF 10A	AZD7762	0.04	uM	LJP6	2	L06	72	hr	962	10148	10605	0.9569	0.9526
MCF 10A	AZD7762	0.04	uM	LJP6	3	L06	72	hr	962	9616	10605	0.9067	0.8974
MCF 10A	Afatinib	0.04	uM	LJP6	1	G24	72	hr	962	1738	10605	0.1639	0.0805
MCF 10A	Afatinib	0.04	uM	LJP6	2	G24	72	hr	962	1652	10605	0.1558	0.0715
MCF 10A	Sigma A6730	0.04	uM	LJP5	1	B24	72	hr	962	10370	10605	0.9778	0.9756
MCF 10A	Sigma A6730	0.04	uM	LJP5	2	B24	72	hr	962	10789	10605	1.0173	1.0191
MCF 10A	Alvocidib	0.04	uM	LJP6	2	A18	72	hr	962	814	10605	0.0768	-0.0154
MCF 10A	Alvocidib	0.04	uM	LJP6	3	A18	72	hr	962	740	10605	0.0698	-0.0230
MCF 10A	AT-7519	0.04	uM	LJP6	2	K06	72	hr	962	10085	10605	0.9510	0.9461
MCF 10A	AT-7519	0.04	uM	LJP6	3	K06	72	hr	962	9348	10605	0.8815	0.8696
MCF 10A	AZD-6482	0.04	uM	LJP5	1	I06	72	hr	962	10728	10605	1.0116	1.0127
MCF 10A	AZD8330	0.04	uM	LJP5	1	G24	72	hr	962	1627	10605	0.1534	0.0689
MCF 10A	AZD8055	0.04	uM	LJP6	3	A12	72	hr	962	3809	10605	0.3592	0.2952

<
<<
Previous
Page 1 of 497
Next
>>
>
1 to 25 of 12420 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)